Selected Recent Domestic Transactions

in its acquisition by

May 2022

$16 billion

modified Dutch auction tender offer to repurchase its common stock

May 2022

$400 million

in its acquisition of

Apr 2022

$540 million

in its agreement with Carl C. Icahn relating to the composition of Bausch + Lomb's Board following Bausch Health's spin-off of Bausch + Lomb

Apr 2022

in its response to activism and a proxy contest by Land & Buildings, achieving a full withdrawal of Land & Buildings' director nominations, including its founder Jonathan Litt

Apr 2022

in its acquisition by

Apr 2022

$7.6 billion

in its PIPE investment in

Apr 2022

$20 million

in its all-cash acquisition of

Apr 2022

$250 million

in its entry into the Nomination and Cooperation Agreement with Sherborne Investors

Apr 2022

in its business combination with Riverview Acquisition

Apr 2022

$1.086 billion

in the divestiture of its Leveraged Commentary and Data business and its related family of leveraged loan indices to

Apr 2022

$650 million

in its response to a unsolicited offer by

Mar 2022

$6.6 billion